Profile
Reina Benabou worked as the Head-Global Medical Product Evaluation at Pfizer Inc. from 2012 to 2013.
She then worked as the VP & Head-Global Medical Communications at Novartis Pharma AG from 2014 to 2016.
From 2018 to 2020, she served as the Chief Medical Officer & Senior Vice President at Cognivue, Inc. In 2020, she became the Chief Development Officer & Senior Vice President at BioXcel Therapeutics, Inc. Dr. Benabou holds a doctorate degree from the University of Montréal and the University of Sao Paulo.
Former positions of Reina Benabou
| Companies | Position | End |
|---|---|---|
| BIOXCEL THERAPEUTICS, INC. | Corporate Officer/Principal | 30/07/2021 |
Cognivue, Inc.
 Cognivue, Inc. Medical SpecialtiesHealth Technology Cognivue, Inc. provides health care systems for cognitive, cervical cancer, diabetes, cholesterol, colon cancer, etc. The firm product is Cognivue, which is used for the computerized test of cognitive function. The company is headquartered in Victor, NY. | Chief Tech/Sci/R&D Officer | 01/01/2020 |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Public Communications Contact | 01/01/2016 |
| PFIZER, INC. | Corporate Officer/Principal | 01/01/2013 |
Training of Reina Benabou
| University of Montréal | Doctorate Degree |
| University of Sao Paulo | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| BIOXCEL THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
Cognivue, Inc.
Cognivue, Inc. Medical SpecialtiesHealth Technology Cognivue, Inc. provides health care systems for cognitive, cervical cancer, diabetes, cholesterol, colon cancer, etc. The firm product is Cognivue, which is used for the computerized test of cognitive function. The company is headquartered in Victor, NY. | Health Technology |
- Stock Market
- Insiders
- Reina Benabou
